期刊文献+

抗组胺耐药慢性荨麻疹与补体C5a、症状评分及风团持续时间的相关性 被引量:7

Correlation between Antihistamine-resistant Chronic Urticarial and C5a Concentration,Symptom Scores and Duration of Wheals
下载PDF
导出
摘要 目的探讨抗组胺耐药慢性荨麻疹(chronic urticaria,CU)的相关影响因素。方法检测抗组胺敏感CU及抗组胺耐药CU患者血浆凝血因子[凝血酶原片段F1+2(prothrombin fragment 1+2,F1+2)、组织因子(tissue factor,TF)]、抗凝因子[血栓调节蛋白(thrombomodulin,TM)]、纤溶标志物[高分子量激肽原(high molecular weight kininogen,HMWK)、组织型纤溶酶原激活剂(tissue plasminogen activator,t-PA)]、补体(C5a、C3、C4)、炎性标志物[红细胞沉降率(erythrocyte sedimentation rate,ESR)、抗溶血性链球菌O(anti-streptolysin"O",ASO)、C-反应蛋白(C-reactive protein,CRP)、类风湿因子(rheumatoid factor,RF)]水平,分析上述指标及CU病情等与CU抗组胺药物治疗反应的关系。结果与敏感CU患者[(40.43±10.89)ng/ml]比较,抗组胺药耐受CU患者C5a水平[(50.67±16.83)ng/ml]升高且差异有统计学意义(P<0.05),血浆F1+2、TF、TM、HMWK、t-PA、C3、C4、ESR、ASO、RF及CRP水平差异无统计学意义(均P>0.05)。抗组胺药物敏感与否与症状评分及风团持续时间相关(r=0.42,P<0.01;r=0.57,P<0.01)。结论抗组胺耐药CU患者血浆C5a水平升高、症状评分较高且风团持续时间较长,提示抗组胺耐药CU患者病情更严重且存在更复杂的自身免疫因素。 To investigate the influencing factor for antihistamine-resistant chronic urticaria. Methods The plasma level of prothrombin fragment 1 + 2 (F1 + 2), tissue factor (TF), thrombomodulin (TM), high molecular weight kininogen (HMWK), tissue-type plasminogen activator (t-PA), CSa and serum levels of C3, C4, erythrocyte sedimentation rate (ESR), anti-streptolysin O (ASO), rheumatoid factors (RF) and C-reactive protein (CRP) were detected in patients with antihistamine-resistant and antihistamine-sensitive chronic urticaria. Results Plasma concentrations of CSa in patients with antihistamines-resistant chronic urticaria [ (50.67 ±16. 83 ) ng/ml] between the higher than in patients with antihistamine-sensitive chronic urticatia [ (40.43 ± 10. 89) ng/ml ] , the difference was statistically significant (P 〈0.05 ). But there was no significant difference between the plasma level of F1 + 2, TF, TM, HMWK, t-PA and serum levels of C3, C4, ESR, ASO, RF and CRP in two patients groups (P 〉 0. 05). The responsiveness to antihistamines was correlated with symptom scores and duration of wheals (r = 0. 42, P 〈 0.01 ; r = 0. 57, P 〈 0.01 ). Conclusion The increased C5a concentration, higher symptom scores and longer duration of wheals was shown in patients with antihistamines-resistant chronic urticarial.
出处 《中华临床免疫和变态反应杂志》 2013年第4期309-313,共5页 Chinese Journal of Allergy & Clinical Immunology
基金 广东省自然科学基金(S2012020011077) 广州市医药卫生科技项目(20131A011128)
关键词 慢性荨麻疹 凝血 补体 炎性标志物 抗组胺耐药 chonic urticaria coagulation complements inflammation markers antihistamine-resistant
  • 相关文献

参考文献12

  • 1Asero R, Tedeschi A, Coppola R, et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticarial [ J ]. J Allergy Clin Immunol, 2007, 119:705-710.
  • 2Asero R, Tedeschi A, Riboldi P, et al. Severe chronic urticaria is associated with elevated plasma levels of D-dimer [Jl- Allergy, 2008, 63:176-180.
  • 3Takedal T, Sakurail Y, Takahagi S, et al. Increase of coagulation potential in chronic spontaeous urticarial Ill. Allergy, 2011, 66:428-433.
  • 4梁碧华,肖常青,林路洋,李振洁,李润祥,叶兴东,罗静英,朱慧兰.凝血、抗凝血以及纤溶系统与荨麻疹发病的关系[J].中国麻风皮肤病杂志,2010,26(2):102-104. 被引量:6
  • 5Asero R, Tedeschi A, Cugno M. Heparin and tranexamic Acid therapy may be effective in treatment- resistant chronic urticaria with elevated d-dimer: a pilot study [J]. Int Arch Allergy Irnmunol, 2010, 152:384- 389.
  • 6Chua SL, Gibbs S. Chronic urticaria responding to subcutaneous heparin sodium [ J ]. Br J Dermatol, 2005, 153:216-217.
  • 7Parslew R, Pryce D, Ashworth J, et al. Warfarin treatment of chronic idiopathic urticaria and anglo-edema [J]. Clin Exp Allergy, 2000, 30:1161-1165.
  • 8刘小明,盛晚香,周芬,周武.地氯雷他定联合潘生丁治疗慢性荨麻疹疗效观察[J].中国皮肤性病学杂志,2007,21(7):443-444. 被引量:7
  • 9Magen E, Mishal J, Zeldin Y, et al. Clinical and laboratory features of antihistamine-resistant chronic idiopathic urticaria [ J]. Allergy Asthma Proc, 2011, 32:460-466.
  • 10Hu ber-Lang M, Sarma JV, Zetoune FS, et al. Generation of CSa in the absence of C3: a new complement activation pathway [ J]. Nat Med, 2006, 12:682-687.

二级参考文献14

  • 1林挺,王俊杰,廖元兴.仙特敏治疗荨麻疹的疗效观察[J].临床皮肤科杂志,1995,24(3):181-181. 被引量:9
  • 2Asero R, Tedeschi A, Lorini M, et al, Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 2001 ;31(7) : 1105 - 1110.
  • 3Asem R, Tedeschi A, Riboldi P, et al. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal- and- tlare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117 (5) : 1113 - 1117.
  • 4Asero R, Tedeschi A, Coppola R, et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clinical Immunology 2(107; 119(3) :705 - 710.
  • 5Cugno M, Marzano AV, Tedeschi A, et al. Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Immunol 2008; 148(2):170- 174.
  • 6Parslew R, Pryce D, Ashworth J, et al. Warfarin treatment of chronic idiopathic urticaria and angio- oedema. Clin Exp Allergy 2000;30(8) : 1161 - 1165.
  • 7Chua SL, Gibbs S. Chronic urticaria responding to subcutaneous heparin sodium. Br J Dermatol 2005; 153(1) :216 - 217.
  • 8Schaeffer RC, Gong F, Bitrick MS, et al. Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms. Am J Physiol 1993 ;264:1798 - 1809.
  • 9Kido H, Fukusen N, Katunuma N, et al. Tryptase from rat mast cells converts bovine prothrombin to thrombin. Bioche Biophys Res Commun 1985; 132:613 - 619.
  • 10Asero R, Tedeschi A, Riboldi P, et al. Severe chronic urticaria is associated with elevated plasma levels of D- dimer. Allergy 2008; 63(2) : 176 - 180.

共引文献11

同被引文献75

引证文献7

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部